- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Soliton secures acquisition deal
AbbVie subsidiary Allergan Aesthetics has agreed to acquire Soliton, which is commercialising a cellulite treatment based on research at University of Texas.
May 11, 2021ESS charges up $1.1bn reverse merger
SoftBank vehicle SB Energy and BASF contributed to a $250m PIPE financing that will support the merger with the Nasdaq-listed Acon S2 Acquisition Corp.
May 11, 2021Safar Partners attracts $191m
The venture fund, focused on companies out of MIT, Harvard and Rochester, has collected more than $191m on its way to a $325m target.
May 11, 2021Kin Insurance constructs series C
CSAA-backed digital home insurance provider Kin secured $63.9m to increase its overall funding to about $150m.
May 11, 2021Singular Genomics to mingle with public markets
The genetic sequencing technology developer has filed to raise up to $100m, having secured nearly $150m from investors including Legend Capital in the past two years.
May 11, 2021Kin constructs series C
UChicago once again invested in Kin Insurance, participating in a $63.9m series C round that brought its overall funding to nearly $150m.
May 11, 2021Innovusion inputs $64m in series B funding
The autonomous driving technology developer is looking to ramp up production with capital from investors including Nio and Bertelsmann.
May 11, 2021Virogin generates $80m in financing
The Sinopharm-backed oncology drug developer has raised series D1 funding in a round led by China Structural Reform Fund Corporation.
May 11, 2021Sirclo secures $45m in series B3 round
The e-commerce software provider received funding in a round led by Sinar Mas subsidiary SMDV at a reported $116m valuation.
May 11, 2021Daily Deal Round Up: May 10, 2021
Legend Holdings' Legend Star unit led a round for optical chip producer Turing Quantum sized above $15m while several Japanese companies also raised money.
May 10, 2021Gyroscope Therapeutics gives up $149m IPO
Cambridge’s gene therapy developer had set terms for an offering set to raise between $135m and $149m on the Nasdaq Global Select Market.
May 10, 2021Lightmatter illuminates $80m series B
The photonic computing technology spinout of MIT has now pocketed $113m in funding altogether.
May 10, 2021Featured Content
GCV Powerlist 2026Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.GCV Powerlist 2026
Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
